ADMA Biologics (ADMA) Prelim. Q4 Revenue Tops Consensus
Go back to ADMA Biologics (ADMA) Prelim. Q4 Revenue Tops Consensus| ADMA Biologics Inc Com (NASDAQ: ADMA) | Delayed: 8.97 -0.11 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.08 | 52 Week High | $9.65 | |||
| Open | $9.16 | 52 Week Low | $4.15 | |||
| Day High | $9.22 | P/E | N/A | |||
| Day Low | $8.88 | EPS | $-0.01 | |||
| Volume | 2,874,234 | |||||

